Transcatheter Valve Solutions
Our minimally invasive transcatheter solutions are proven to safely, effectively repair or replace heart valves for patients and deliver excellent outcomes.
MITRACLIP™
TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER)
Abbott is the established leader in transcatheter edge-to-edge repair (TEER)—with MitraClip™ therapy. MitraClip TEER is a minimally invasive mitral valve repair therapy that delivers a life-changing treatment option for select patients with mitral regurgitation who would otherwise go untreated.1
TRICLIP™
TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER)
TriClip™ TEER offers a minimally invasive treatment option for patients with symptomatic, severe tricuspid regurgitation, built upon our proven clip-based technology.
TRICLIP™
TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER)
TriClip™ TEER System offers a minimally invasive treatment option for patients with symptomatic, severe tricuspid regurgitation, built upon our proven clip-based technology.
TENDYNE™
TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR)
Tendyne™ TMVR System is first-in-class technology designed to eliminate mitral regurgitation (MR), offering select patients with MR (≥ grade 3), a minimally invasive option for mitral valve replacement.
NAVITOR™ TAVI SYSTEM
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
Navitor™ TAVI System offers intelligent design advantages to consistently achieve excellent outcomes across a spectrum of routine to challenging anatomies in patients with severe aortic valve stenosis who are at high or greater risk for surgery.2
NAVITOR™ WITH FLEXNAV™
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
Navitor™ TAVI system offers intelligent design advantages, including smart PVL-sealing NaviSeal™ Cuff, stable and accurate placement, exceptional single-digit gradients,2 and uncompromised small vessel access and coronary access to consistently achieve excellent outcomes across a spectrum of routine to challenging anatomies.
MAT-2201423 v2.0 | Item approved for OUS use only.